retatrutide fda approval status 2025 This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway October 27, 2025: U.K. regulators
Description
Youre already starting to see it percolate on social media, he explains
What is the recommended dose of Retatrutide
Sleep Apnea: Causes breathing interruptions and fatigue, while increasing the risk of hypertension and heart disease
"FDA approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity" (Press release)
There is no magic bullet for obesity
Typically, dose escalation begins at 0.25mg weekly and increases incrementally to a maximum of 2.4mg if well-tolerated
